Press Releases

NORTHAMPTON, MA / ACCESSWIRE / May 31, 2024 / KeyBankGrants were announced during the opening of the third season of the KeyBank Delavan-Grider Farmers Market and will go to two organizations with established track records of working to improve access to healthy, fresh and nutritious food in East Buffalo

A $450,000 investment from the KeyBank Foundation will help two organizations working to fight food insecurity in East Buffalo. This investment was announced at the... (continue reading...)

NEW YORK, May 31, 2024 /PRNewswire/ -- Piscifun, a leading innovator in the fishing industry, continues to push the boundaries of gear technology with the introduction of its new Saltflow High-Tech Rods for offshore saltwater fishing. Designed to meet the demand of battling massive offshore species, these rods represent a significant leap forward in performance and durability.

Offshore saltwater fishing presents a unique set of obstacles, from powerful fish that can... (continue reading...)

NORTHAMPTON, MA / ACCESSWIRE / May 31, 2024 / Tarynn Zenk, vice president of accounting and ESG controller at Mastercard, joins co-host Mandi McReynolds on the latest episode of ESG Talk to discuss the growing role of ESG controllers within companies. Discover how ESG controllers navigate the intersection of finance and sustainability, safeguarding the credibility of companies' ESG disclosures.

Listen Now

Looking for more? Subscribe to the ESG Talk podcast on Apple, ... (continue reading...)

NORTHAMPTON, MA / ACCESSWIRE / May 31, 2024 / MaximusAsian American, Native Hawaiian and Pacific Islanders (AANHPI) ERG members share their stories during AANHPI Heritage Month

ERGs Unplugged is our internal diversity, equity, and inclusion (DE&I) podcast, where we take a deeper dive into the power of our Employee Resource Groups (ERGs). In our second episode, we chatted with Asian American, Native Hawaiian, and Pacific Islanders (AANHPI) ERG members Joanne Ruan, Dominic... (continue reading...)

xM MRD and NeXT Personal Dx tests are now available for physicians in the U.S. for early cancer recurrence detection and residual disease monitoring

CHICAGO--(BUSINESS WIRE)-- Tempus, a leader in artificial intelligence and precision medicine, today announced the clinical launch of its minimal residual disease (MRD) test portfolio, including Tempus’ xM test and the xM (NeXT Personal® Dx) test by Personalis. The portfolio features both a tumor-naïve assay and... (continue reading...)